ADSTILADRIN
000425
Phase 2 small_molecule active
Quick answer
ADSTILADRIN for Low-grade upper track urothelial carcinoma (LG-UTUC) is a Phase 2 program (small_molecule) at Ferring Pharmaceuticals A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ferring Pharmaceuticals A/S
- Indication
- Low-grade upper track urothelial carcinoma (LG-UTUC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active